(Q40685230)

22 September 2017

Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma (English)

1 reference

medroxyprogesterone acetate

22 September 2017

1 reference

1 reference

1 reference

M Kriegmair

1

1 reference

22 September 2017

R Oberneder

series ordinal

2

1 reference

22 September 2017

A Hofstetter

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

22 September 2017

1 reference

22 September 2017

45

1 reference

22 September 2017

758-762

1 reference

22 September 2017

5

1 reference

Current status of the therapy of advanced renal carcinoma

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980079-X

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980079-X

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980079-X

7 January 2021

Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980079-X

7 January 2021

Interleukin-2 in combination with interferon-alpha and 5-fluorouracil for metastatic renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980079-X

7 January 2021

Combination of recombinant interferon alpha-2a and vinblastine in advanced renal cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980079-X

7 January 2021

10.1016/S0090-4295(99)80079-X

Identifiers

DOI

1 reference

22 September 2017

1 reference